Table 1.
Viral mutant |
CMT-64 |
CMT-93 |
JC |
LNCaP |
||||
---|---|---|---|---|---|---|---|---|
T | C | T | C | T | C | T | C | |
Ad5 | S | S | S | S | A | A | S | S |
dl309 | S | S | S | S | A | A | S | S |
dl704 | S | S | S | S | A | A | S | S |
dl312 | ne | ne | ne | ne | ne | ne | ne | ne |
Abbreviations: C, cisplatin; ne, no effect; T, paclitaxel.
T or C were given 24 h prior to infection with viruses.
S or A in at least 3/4 data points with no clear antagonism or synergy respectively; ne is no sensitization to virus and no effect on drug induced cell death; data represent 4–8 combinations for each condition.